APO RESEARCH · REPORT
Donepezil
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Product & engineering
Understand the product.
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.
Selected research
Industry Research
Donepezil Industry Research Report 2026
Market perspective
North America is the main market for donepezil, accounting for about 35% of the total market, followed by Europe with about 30%.
Donepezil's major manufacturers include Eisai, Pfizer, Teva, Novartis, etc. The top three companies account for about 60% of the market.
The classification of Donepezil includes 5mg, 10mg and 23mg, and the proportion of 10mg in 2017 is about 48%.
Read the full market overview
Report Scope
This report quantifies the global Donepezil market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Donepezil Market by Company
Eisai
Pfizer
Teva
Sandoz
Apotex
Dr Reddy's Laboratories
Sun Pharmaceutical
Hansoh Pharma
Cipla
ARK PHA.LTD
Jishengtang Pharma
Luoxin
Donepezil Segment by Type
5mg
10mg
23mg
Donepezil Segment by Application
Hospitals
Clinics
Drugstore
Donepezil Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Donepezil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Donepezil manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Donepezil by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Donepezil in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 10mg
- 23mg
Applications
- Hospitals
- Clinics
- Drugstore
Companies covered
- Eisai
- Pfizer
- Teva
- Sandoz
- Apotex
- Dr Reddy's Laboratories
- Sun Pharmaceutical
- Hansoh Pharma
- Cipla
- ARK PHA.LTD
- Jishengtang Pharma
- Luoxin
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Donepezil Market Size (2021-2032)
- 2.2.2 Global Donepezil Sales (2021-2032)
- 2.2.3 Global Donepezil Market Average Price (2021-2032)
- 2.3 Donepezil by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 5mg
- 2.3.3 10mg
- 2.3.4 23mg
- 2.4 Donepezil by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Drugstore
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Donepezil Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Donepezil Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Donepezil Revenue of Manufacturers (2021-2026)
- 3.4 Global Donepezil Average Price by Manufacturers (2021-2026)
- 3.5 Global Donepezil Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Donepezil, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Donepezil, Product Type & Application
- 3.8 Global Manufacturers of Donepezil, Established Date
- 3.9 Global Donepezil Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eisai
- 4.1.1 Eisai Company Information
- 4.1.2 Eisai Business Overview
- 4.1.3 Eisai Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eisai Donepezil Product Portfolio
- 4.1.5 Eisai Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Donepezil Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Teva
- 4.3.1 Teva Company Information
- 4.3.2 Teva Business Overview
- 4.3.3 Teva Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Teva Donepezil Product Portfolio
- 4.3.5 Teva Recent Developments
- 4.4 Sandoz
- 4.4.1 Sandoz Company Information
- 4.4.2 Sandoz Business Overview
- 4.4.3 Sandoz Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sandoz Donepezil Product Portfolio
- 4.4.5 Sandoz Recent Developments
- 4.5 Apotex
- 4.5.1 Apotex Company Information
- 4.5.2 Apotex Business Overview
- 4.5.3 Apotex Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Apotex Donepezil Product Portfolio
- 4.5.5 Apotex Recent Developments
- 4.6 Dr Reddy's Laboratories
- 4.6.1 Dr Reddy's Laboratories Company Information
- 4.6.2 Dr Reddy's Laboratories Business Overview
- 4.6.3 Dr Reddy's Laboratories Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dr Reddy's Laboratories Donepezil Product Portfolio
- 4.6.5 Dr Reddy's Laboratories Recent Developments
- 4.7 Sun Pharmaceutical
- 4.7.1 Sun Pharmaceutical Company Information
- 4.7.2 Sun Pharmaceutical Business Overview
- 4.7.3 Sun Pharmaceutical Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sun Pharmaceutical Donepezil Product Portfolio
- 4.7.5 Sun Pharmaceutical Recent Developments
- 4.8 Hansoh Pharma
- 4.8.1 Hansoh Pharma Company Information
- 4.8.2 Hansoh Pharma Business Overview
- 4.8.3 Hansoh Pharma Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hansoh Pharma Donepezil Product Portfolio
- 4.8.5 Hansoh Pharma Recent Developments
- 4.9 Cipla
- 4.9.1 Cipla Company Information
- 4.9.2 Cipla Business Overview
- 4.9.3 Cipla Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cipla Donepezil Product Portfolio
- 4.9.5 Cipla Recent Developments
- 4.10 ARK PHA.LTD
- 4.10.1 ARK PHA.LTD Company Information
- 4.10.2 ARK PHA.LTD Business Overview
- 4.10.3 ARK PHA.LTD Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 ARK PHA.LTD Donepezil Product Portfolio
- 4.10.5 ARK PHA.LTD Recent Developments
- 4.11 Jishengtang Pharma
- 4.11.1 Jishengtang Pharma Company Information
- 4.11.2 Jishengtang Pharma Business Overview
- 4.11.3 Jishengtang Pharma Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Jishengtang Pharma Donepezil Product Portfolio
- 4.11.5 Jishengtang Pharma Recent Developments
- 4.12 Luoxin
- 4.12.1 Luoxin Company Information
- 4.12.2 Luoxin Business Overview
- 4.12.3 Luoxin Donepezil Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Luoxin Donepezil Product Portfolio
- 4.12.5 Luoxin Recent Developments
5 Global Donepezil Market Scenario by Region
- 5.1 Global Donepezil Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Donepezil Sales by Region: 2021-2032
- 5.2.1 Global Donepezil Sales by Region: 2021-2026
- 5.2.2 Global Donepezil Sales by Region: 2027-2032
- 5.3 Global Donepezil Revenue by Region: 2021-2032
- 5.3.1 Global Donepezil Revenue by Region: 2021-2026
- 5.3.2 Global Donepezil Revenue by Region: 2027-2032
- 5.4 North America Donepezil Market Facts & Figures by Country
- 5.4.1 North America Donepezil Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Donepezil Sales by Country (2021-2032)
- 5.4.3 North America Donepezil Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Donepezil Market Facts & Figures by Country
- 5.5.1 Europe Donepezil Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Donepezil Sales by Country (2021-2032)
- 5.5.3 Europe Donepezil Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Donepezil Market Facts & Figures by Country
- 5.6.1 Asia Pacific Donepezil Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Donepezil Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Donepezil Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Donepezil Market Facts & Figures by Country
- 5.7.1 South America Donepezil Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Donepezil Sales by Country (2021-2032)
- 5.7.3 South America Donepezil Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Donepezil Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Donepezil Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Donepezil Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Donepezil Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Donepezil Sales by Type (2021-2032)
- 6.1.1 Global Donepezil Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Donepezil Sales Market Share by Type (2021-2032)
- 6.2 Global Donepezil Revenue by Type (2021-2032)
- 6.2.1 Global Donepezil Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Donepezil Revenue Market Share by Type (2021-2032)
- 6.3 Global Donepezil Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Donepezil Sales by Application (2021-2032)
- 7.1.1 Global Donepezil Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Donepezil Sales Market Share by Application (2021-2032)
- 7.2 Global Donepezil Revenue by Application (2021-2032)
- 7.2.1 Global Donepezil Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Donepezil Revenue Market Share by Application (2021-2032)
- 7.3 Global Donepezil Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Donepezil Value Chain Analysis
- 8.1.1 Donepezil Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Donepezil Production Mode & Process
- 8.2 Donepezil Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Donepezil Distributors
- 8.2.3 Donepezil Customers
9 Global Donepezil Analyzing Market Dynamics
- 9.1 Donepezil Industry Trends
- 9.2 Donepezil Industry Drivers
- 9.3 Donepezil Industry Opportunities and Challenges
- 9.4 Donepezil Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst